Sun Pharma Advanced Research Company has informed that the Securities Allotment Committee of the company, has in its meeting held from 12:00 Noon to 12:45 pm today, allotted 60,60,606 fully paid-up equity shares of face value of Re 1 each of the company on conversion of equivalent number of warrants consequent to the receipt of application for exercise of option along with exercise money aggregating to Rs 1,499,999,985 from its warrant holders.
The above information is a part of company’s filings submitted to BSE.
